Cinctive Capital Management’s Apellis Pharmaceuticals APLS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $826K | Buy |
+47,700
| New | +$826K | 0.04% | 267 |
|
|
2025
Q1 | – | Sell |
-86,991
| Closed | -$2.78M | – | 304 |
|
|
2024
Q4 | $2.78M | Buy |
+86,991
| New | +$2.78M | 0.14% | 181 |
|
|
2024
Q3 | – | Sell |
-37,875
| Closed | -$1.45M | – | 368 |
|
|
2024
Q2 | $1.45M | Buy |
37,875
+2,881
| +8% | +$111K | 0.07% | 254 |
|
|
2024
Q1 | $2.06M | Buy |
34,994
+29,046
| +488% | +$1.71M | 0.1% | 205 |
|
|
2023
Q4 | $356K | Buy |
+5,948
| New | +$356K | 0.02% | 320 |
|
|
2022
Q3 | – | Sell |
-31,654
| Closed | -$1.43M | – | 435 |
|
|
2022
Q2 | $1.43M | Buy |
31,654
+3,600
| +13% | +$163K | 0.06% | 317 |
|
|
2022
Q1 | $1.43M | Buy |
28,054
+502
| +2% | +$25.5K | 0.05% | 311 |
|
|
2021
Q4 | $1.3M | Sell |
27,552
-23,448
| -46% | -$1.11M | 0.06% | 340 |
|
|
2021
Q3 | $1.68M | Buy |
+51,000
| New | +$1.68M | 0.08% | 307 |
|